QSAM Biosciences RSI
Qual é o RSI de QSAM Biosciences?
O RSI de QSAM Biosciences, Inc. é 68.60
Qual é a definição de RSI?
O índice de força relativa (RSI 14) é um indicador de momento que compara a magnitude de ganhos e perdas em um período de tempo especificado para medir a velocidade e a variação dos movimentos de preço de um título.
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI de empresas na Setor Health Care em OTC em comparação com QSAM Biosciences
O que QSAM Biosciences faz?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
Empresas com rsi semelhantes a QSAM Biosciences
- Real Estate & E-Comm Split tem RSI de 68.58
- Templeton Global Growth Fund tem RSI de 68.58
- Dolly Varden Silver tem RSI de 68.58
- Majestic Gold tem RSI de 68.58
- TCW Strategic Income Fund Inc tem RSI de 68.59
- LHN tem RSI de 68.59
- QSAM Biosciences tem RSI de 68.60
- SK Telecom Co Ltd tem RSI de 68.61
- GFL tem RSI de 68.61
- EPR Properties tem RSI de 68.61
- Alembic Pharmaceuticals tem RSI de 68.61
- Marico tem RSI de 68.62
- Calnex Solutions Plc tem RSI de 68.63